Shabnam Fayezi

Shabnam Fayezi

Auto-generated profile, based on publicly available information

Shabnam Fayezi

Department of Gynecologic Endocrinology and Fertility Disorders, Women’s Hospital, Ruprecht-Karls University of Heidelberg, Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2023 in Reviews in Endocrine and Metabolic Disorders
Verified
Journal Article
Open access
PDF file
ZGZeinab Ghesmati
Zeinab Ghesmati
MRMohsen Rashid
Mohsen Rashid
SFShabnam Fayezi
Shabnam Fayezi
FGFrank Gieseler
Frank Gieseler
EAEffat Alizadeh
Effat Alizadeh
MDMasoud Darabi
Masoud Darabi
Adipose tissue, including white adipose tissue (WAT), brown adipose tissue (BAT), and beige adipose tissue, is vital in modulating whole-body energy metabolism. While WAT primarily stores energy, BAT dissipates energy as heat for thermoregulation. Beige adipose tissue is a hybrid form of adipose tissue that shares characteristics with WAT and BAT. Dysregulation of adipose tissue metabolism is linked to various disorders, including obesity, type 2 diabetes, cardiovascular diseases, cancer, and infertility. Both brown and beige adipocytes secrete multiple molecules, such as batokines, packaged in extracellular vesicles or as soluble signaling molecules that play autocrine, paracrine, and endocrine roles. A greater understanding of the adipocyte secretome is essential for identifying novel molecular targets in treating metabolic disorders. Additionally, microRNAs show crucial roles in regulating adipose tissue differentiation and function, highlighting their potential as biomarkers for metabolic disorders. The browning of WAT has emerged as a promising therapeutic approach in treating obesity and associated metabolic disorders. Many browning agents have been identified, and nanotechnology-based drug delivery systems have been developed to enhance their efficacy. This review scrutinizes the characteristics of and differences between white, brown, and beige adipose tissues, the molecular mechanisms involved in the development of the adipocytes, the significant roles of batokines, and regulatory microRNAs active in different adipose tissues. Finally, the potential of WAT browning in treating obesity and atherosclerosis, the relationship of BAT with cancer and fertility disorders, and the crosstalk between adipose tissue with circadian system and circadian disorders are also investigated.

1 January 2014 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
FMFatemeh Mohammadzadeh
Fatemeh Mohammadzadeh
GMGholamali Mosayebi
Gholamali Mosayebi
VMVahid Montazeri
Vahid Montazeri
MDMaryam Darabi
Maryam Darabi
SFShabnam Fayezi
Shabnam Fayezi
MDMasoud Darabi
Masoud Darabi
Mohammadzadeh F, et al. J Breast Cancer. 2014 Jun;17(2):136-142. https://doi.org/10.4048/jbc.2014.17.2.136

17 December 2015 in Development, Growth & Differentiation
Verified
Journal Article
Closed access
PDF file
YRYaghoub Rahimi
Yaghoub Rahimi
AMAmir Mehdizadeh
Amir Mehdizadeh
HCHojjatollah Nozad Charoudeh
Hojjatollah Nozad Charoudeh
MNMohammad Nouri
Mohammad Nouri
KVKobra Valaei
Kobra Valaei
MDMasoud Darabi
Masoud Darabi

1 January 2012
Verified
Journal Article
Open access
BYBahman Yousefi
Bahman Yousefi
MDMasoud Darabi
Masoud Darabi
Behzad BaradaranBehzad Baradaran
Behzad Baradaran
MKMahmoud Shekari Khaniani
Mahmoud Shekari Khaniani
MRMohammad Rahbani
Mohammad Rahbani
MSMaghsod Shaaker
Maghsod Shaaker
Introduction: The extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase pathway, also known as the MEK/ERK1/2 kinase cascade, has recently been implicated in the regulation of lipid metabolism and fatty liver disease. However, its functional effect on cellular fatty acid composition is unknown. Herein, we examined the effect of a pharmacological inhibitor of MEK, the upstream kinase activator of ERK1/2, on fatty acid composition of hepatocellular carcinoma cell line HepG2. Methods: HepG2 cells cultured in RPMI-1640 were exposed to the commonly used ERK1/2 pathway inhibitor PD98059 and were investigated with respect to fatty acid composition by gas-liquid chromatography. Results: Exposure of cells to the ERK1/2 pathway inhibitor induced an increase in monounsaturated fatty acids and the fatty acid desaturation index and a decrease in polyunsaturated fatty acid content. Specifically, we showed a significant increase of oleic acid (18:1n-9; +29%, P=0.003) and arachidonic acid (20: 4n-6)/linoleic acid (18:2n-6) ratio (3.5-fold; P<0.001) in HepG2 cells. Conclusion: Cellular fatty acid composition of HepG2 cells appeared to be differentially regulated by ERK1/2 pathway, thus suggesting related metabolic pathways as potential mediators of the effects of ERK1/2 signaling on hepatic fatty acid composition.

29 January 2014 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
SFS. Fayezi
S. Fayezi
MDM. Darabi
M. Darabi
MNM. Nouri
M. Nouri
ARA. Rahimipour
A. Rahimipour
AMA. Mehdizadeh
A. Mehdizadeh
Follicular fluid (FF) samples were obtained from 100 patients referred to the University Hospital. A total of 79 subjects underwent IVF and the remaining 21 underwent ICSI. The levels of apoA-I and total phospholipid were measured using turbidometric and colorimetric phosphorus assays, respectively. Correlation analysis showed a significant inverse association of total phospholipid in FF with fertilisation ratio (r = -0.24, p = 0.04). Furthermore, the ratio of phospholipid/apoA-I in patients with a percentage of fertilised oocytes <= 50% was significantly higher (> 2.5%, p < 0.05) than in those with higher percentages of fertilised oocytes. The amounts of phospholipid and phospholipid/apoA-I ratio in FF were associated negatively to the percentage of oocyte fertilisation. Therefore, the change in the phospholipid and phospholipid/apoA-I ratio of FF might be regarded as indicators of female fertility.

29 October 2014 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
MAM. Askari
M. Askari
MDM. Darabi
M. Darabi
RMR. Zare Mahmudabadi
R. Zare Mahmudabadi
MOM. Oboodiat
M. Oboodiat
SFS. Fayezi
S. Fayezi
APA. Pirzadeh
A. Pirzadeh